Additionally, gastrin-releasing peptide receptor (GRPR) was also identified as an important target candidate of DSCR9, and diseases that associated with GRPR include lung cancer and prostate adenocarcinoma. The gene discussed is DSCR9; the disease is lung carcinoma.